Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by skyplton Oct 03, 2019 6:56am
174 Views
Post# 30190905

RE:RE:Profits

RE:RE:Profits
gottahunch held fast to a prediction that was significantly higher  than the analysts. My respect for this call was not so much in being more accurate (and still would have been the winner on The Proce is Right as he did not go over) but holding to the conviction despite noises being made by the Outhere types.

The other individual making a good prediction has left the board.

I am hopeful that between 1 at apparently full production and CC Pharma we are looking at 140M or so.  That is not taking into account any magic numbers associated with the stock price being below an arbitrary price to realize gains on the debentures (in all honesty, I have no idea how that gets shown on the balance sheets).

As always, I am looking for Simon’s forward looking remarks. Surely there has to be something on how they are prepping for Rec 2.0.  A JV with a major beverage or even Pharma would be nice.

If DD is not approved before the AGM there will be a lot of questions.

Geppetto wrote: I saw a post about three weeks ago mentioning two posters on this board that predicted the last earnings very accurately. I hope they chime in although I forget what their names were.
vicpete wrote:
the previous earnings we saw a nice stock increase that has eroded since then. The next earnings should be stronger thus the stock price should surpass the previous spike. Aphria is on the correct path and see them as the strongest cannabis company in Canada.




Bullboard Posts